Analysis of the market reference cost and purchase channel description of Letermovir tablets in 2026

Letermovir tablets (Letermovir) is an antiviral drug mainly used to prevent cytomegalovirus (CMV) infection in patients receiving hematopoietic stem cell transplantation (HSCT). The drug is already on the market in China, available in two dosage forms: tablets and injections, both of which have been included in the scope of medical insurance reimbursement. The inclusion of medical insurance allows patients to have certain financial security in purchasing and using it, and it also facilitates hospitals to promote standardized prevention programs in clinical practice, thereby reducing the risk of CMV infection and related complications.

In the domestic market, the price of letermovir tablets is relatively high, with a box of tablets costing tens of thousands of yuan, while each box of injections is about five to six hundred yuan. The specific selling price will vary according to the real-time pricing of hospital pharmacies in various places. Therefore, patients should consult the hospital pharmacy for the latest price before purchasing, and choose the appropriate dosage form according to the doctor's prescription and treatment plan. The choice of tablets and injections usually depends on the patient's specific condition, oral tolerance, and clinical dosing regimen.

Letermovir is also sold in overseas markets, and generic drugs have appeared in some areas. For example, the tablet version produced by Lucius in Laos sells for about 2,000 yuan per box, which is much cheaper than the original drug, providing a feasible alternative for patients with limited financial conditions. When obtaining drugs through formal overseas channels, patients need to pay attention to the legality, transportation conditions and storage requirements of the drugs to ensure drug quality and efficacy.

Overall, the domestic launch of letermovir tablets and its inclusion in medical insurance have provided patients with reliable drug purchase channels and certain financial support. Tablets and injections have their own applicable scenarios, and patients should choose the most appropriate method of administration under the guidance of a professional doctor. At the same time, combined with the existence of overseas generic drugs, it provides a reference for cross-border drug purchases under special circumstances, but formal channels and prescription management must still be followed to ensure drug safety and maximum efficacy.

Reference materials:https://www.mayoclinic.org/drugs-supplements/letermovir-oral-route/description/drg-20406647